<?xml version="1.0" encoding="utf-8"?>
<iati-activities xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.03" generated-datetime="2026-02-14T16:37:51.9882839+01:00" linked-data-default="http://data-service.theglobalfund.org/api">
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-THA-C-RTF-3</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Stop TB and AIDS through RRTTPR year 2021-23  (STAR 2021-23) - Thailand (01-Jan-2021-31-Dec-2023)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Thailand, TB/HIV, Raks Thai Foundation (Raks Thai)This program has the following goals: To end AIDS by reducing 6,000 HIV new infections in 2019 to less than 1,000 by 2030.  To reduce TB incidence from 153 per 100,000 in 2019 to 135 per 100,000 in 2023. The objectives of this program are: To prevent new HIV infections by reaching, testing and placing on treatment the majority of the 138,000 persons living with HIV in Thailand who still have detectable virus, thus limiting opportunities for continued transmission.  To prevent the transmission of HIV and TB by reaching out to contacts of index cases for testing and treatment if needed and by sustaining intensive behavior change activities, appropriate use of prophylaxis and strategic use of anti-retroviral drugs and LTBI.  To focus intensive efforts on people who inject drugs for HIV prevention, HCV cure, treatment for addiction-related issues and social and legal support.  To actively find HIV and TB cases in the community and health care settings by employing community health workers and peers to reach and recruit 'at risk' and vulnerable populations into HIV testing and TB screening.  To actively use social networks and online platforms to reach and recruit contacts and members of social networks of index cases of HIV and / or TB.  To ensure early and accurate diagnosis of both diseases by improving diagnostic capability, and reducing turn-around time (by using rapid HIV testing and molecular diagnostic techniques for TB).  To integrate activities across HIV and TB programs at national and sub-national levels and ensure sustainability by strengthening linkages between community and health systems.  To prepare Thailand to transition to sustained domestic funding and efficient implementation system by developing its national resources and capacities for technical support and innovation in support of its health sector and community-based HIV and TB efforts</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="15" role="2">
			<narrative xml:lang="en">Raks Thai Foundation</narrative>
		</participating-org>
		<participating-org type="15" role="3">
			<narrative xml:lang="en">Raks Thai Foundation</narrative>
		</participating-org>
		<participating-org type="15" role="4">
			<narrative xml:lang="en">Raks Thai Foundation</narrative>
		</participating-org>
		<other-identifier ref="THA-C-RTFP03" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="4" />
		<activity-date type="1" iso-date="2021-01-01" />
		<activity-date type="2" iso-date="2021-01-01" />
		<activity-date type="3" iso-date="2023-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Philippe, CREACH</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>philippe.creach@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="TH" percentage="100">
			<narrative xml:lang="en">Thailand</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="49">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="26">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="5">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="20">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Addressing stigma, discrimination and violence</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="23">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Community empowerment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Comprehensive sexuality education for AGYW and adolescent boys and young men (ABYM)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Harm reduction interventions for drug use</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Interventions for young key populations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Needle and syringe programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Opioid substitution therapy and other medically assisted drug dependence treatment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Overdose prevention and management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Pre-exposure prophylaxis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Prevention and management of co-infections and co-morbidities (Prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Sexual and reproductive health services, including STIs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="6">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and polices relating to HIV and HIV/TB</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy (“Know Your Rights” campaign)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="7">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Prevention and management of co-infections and co-morbidities (Treatment, care and support)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Case management, clinical operations and therapeutics</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Country-level coordination and planning</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID diagnostics and testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Community-based organizations institutional capacity building</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Community-led advocacy and research</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Community-led monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Social mobilization</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Health products and waste management systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Infection prevention and control, and protection of the health workforce</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Mitigation for HIV programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Mitigation for TB programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Respond to human rights and gender related barriers to services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Risk communication</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Surveillance systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Surveillance: Epidemiological investigation and contact tracing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="12">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Community health workers: In-service training</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Mobile populations: refugees, migrants and internally displaced people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="15">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Mobile populations: refugees, migrants and internally displaced people</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2021-01-01" />
			<period-end iso-date="2021-12-31" />
			<value currency="USD" value-date="2021-01-01">9015505.27</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2022-01-01" />
			<period-end iso-date="2022-12-31" />
			<value currency="USD" value-date="2021-01-01">16888111.88</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2023-01-01" />
			<period-end iso-date="2023-12-31" />
			<value currency="USD" value-date="2021-01-01">13003651.01</value>
		</budget>
		<transaction ref="cecd6b62-b27a-4035-b3b8-ce2a488ae280">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-06-27" />
			<value currency="USD" value-date="2025-06-27">-86333.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="67144fe1-95e2-4b10-9935-9ae5bcf59f78">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-09-24" />
			<value currency="USD" value-date="2021-09-24">-3877541.11</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fa04b19d-252b-47d0-9815-53442f7c7659">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-03-14" />
			<value currency="USD" value-date="2023-03-14">-1022930.01</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="dae74fc7-61a5-48a1-805f-e035feffca6d">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-09-24" />
			<value currency="USD" value-date="2021-09-24">5586664.11</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="08cd2bee-8bc8-4ae1-a44c-fde6a7723e66">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-03-14" />
			<value currency="USD" value-date="2023-03-14">13320997.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1762eb5c-719e-4e6f-9673-dc34a4e49be2">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-12-10" />
			<value currency="USD" value-date="2020-12-10">11374427.28</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="10886f35-c048-49b4-bbd8-f0b89bfb7159">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-03-01" />
			<value currency="USD" value-date="2022-03-01">14148872.07</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a5da29d3-2e03-4498-ae01-b2dd44b58228">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-03-01" />
			<value currency="USD" value-date="2022-03-01">-755456.77</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3cc4c59e-64ce-43c5-ace2-daec580513e5">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-08-29" />
			<value currency="USD" value-date="2023-08-29">3228764.43</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="dc61a657-b40b-43b3-b261-11c99d869278">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-11-28" />
			<value currency="USD" value-date="2023-11-28">2869221.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="14f14ba3-ba7e-4f4c-bec9-9330e9a8cf32">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-11-25" />
			<value currency="USD" value-date="2021-11-25">3122084.34</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0a863232-a2a7-4fbf-9831-8a56de58956a">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-10-01" />
			<value currency="USD" value-date="2021-10-01">1709123.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0a155a3c-c27e-45bf-9c8f-b5861e593c72">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-03-16" />
			<value currency="USD" value-date="2023-03-16">2452347.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cc3f86a9-c7d7-4905-80b3-63d8cc226550">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-05-16" />
			<value currency="USD" value-date="2023-05-16">1874171.77</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="43cfff16-86d1-4bd2-8f97-efde3aa6d9bc">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-09-09" />
			<value currency="USD" value-date="2022-09-09">606685.95</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a43f58da-df13-4907-a7e6-6c451e4c214f">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-07-22" />
			<value currency="USD" value-date="2021-07-22">4630490.26</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b2243897-5e4e-46a9-a895-2169456a450e">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-12-01" />
			<value currency="USD" value-date="2022-12-01">4234454.93</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5f376ae8-37c8-497d-bbbc-d43cdb464498">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-03-16" />
			<value currency="USD" value-date="2023-03-16">1050814.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6de7c911-d073-4b9d-a40a-dfa14ccc356a">
			<transaction-type code="7" />
			<transaction-date iso-date="2025-06-30" />
			<value currency="USD" value-date="2025-06-30">-86333.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="33b56c84-7502-4fe6-aa04-29174ab5005d">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-08-29" />
			<value currency="USD" value-date="2023-08-29">262524.74</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0b9938a1-2d5b-4682-b6ea-279762809932">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-12-16" />
			<value currency="USD" value-date="2020-12-16">2866395.91</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e1cc284b-810c-4825-81f0-394baaa2c089">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-09-09" />
			<value currency="USD" value-date="2022-09-09">1894463.28</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a44c8173-a1e1-4cbf-9369-5aa362253239">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-02-06" />
			<value currency="USD" value-date="2024-02-06">35116.65</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="85e75689-5a1a-4165-b52d-e5353abca082">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-02-06" />
			<value currency="USD" value-date="2024-02-06">215767.25</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9b4d4a19-f124-4329-b33b-b2622137ac65">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-11-28" />
			<value currency="USD" value-date="2023-11-28">1137917.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="437cbac4-0185-4964-aa81-af0f45961705">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-12-01" />
			<value currency="USD" value-date="2022-12-01">353806.55</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a280d322-5f0a-4e7f-9917-56ce0fc2804c">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-03-03" />
			<value currency="USD" value-date="2022-03-03">6036531.35</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/THA-C-RTF" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for THA-C-RTFP03</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="68.64" />
					<actual value="90.70" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="42.89" />
					<actual value="52.10" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="41.90" />
					<actual value="43.80" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-09-30" />
					<target value="83.80" />
					<actual value="83.50" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-12-31" />
					<target value="111.50" />
					<actual value="142.80" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="57.36" />
					<actual value="45.90" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="41.88" />
					<actual value="39.70" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="2.06" />
					<actual value="4.70" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="2.40" />
					<actual value="0.40" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="2.06" />
					<actual value="2.10" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2.05" />
					<actual value="13.20" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="1.37" />
					<actual value="8.20" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-12-31" />
					<target value="4.10" />
					<actual value="18.00" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-09-30" />
					<target value="3.40" />
					<actual value="10.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="5.66" />
					<actual value="14.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="7.03" />
					<actual value="11.70" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-12-31" />
					<target value="11.30" />
					<actual value="55.50" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="5.60" />
					<actual value="10.80" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="3.73" />
					<actual value="16.50" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="5.66" />
					<actual value="41.40" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-09-30" />
					<target value="9.30" />
					<actual value="27.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-12-31" />
					<target value="12.70" />
					<actual value="20.30" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="6.34" />
					<actual value="2.50" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="6.24" />
					<actual value="4.00" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-09-30" />
					<target value="10.40" />
					<actual value="13.80" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="7.87" />
					<actual value="4.30" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="4.20" />
					<actual value="9.80" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="6.33" />
					<actual value="17.80" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of needles and syringes distributed per person who injects drugs per year by needle and syringe programs</narrative>
				</title>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-09-30" />
					<target value="45" />
					<actual value="46" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-12-31" />
					<target value="45" />
					<actual value="60" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="45" />
					<actual value="60" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="45" />
					<actual value="46" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="45" />
					<actual value="43.76" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-12-31" />
					<target value="24.80" />
					<actual value="17.80" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="12.30" />
					<actual value="4.30" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="12.42" />
					<actual value="12.50" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="12.42" />
					<actual value="5.30" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="16.40" />
					<actual value="7.90" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="8.19" />
					<actual value="6.50" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-09-30" />
					<target value="20.50" />
					<actual value="10.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-09-30" />
					<target value="6.70" />
					<actual value="4.80" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="2.68" />
					<actual value="3.30" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="5.01" />
					<actual value="1.30" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="4.03" />
					<actual value="1.50" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="4.03" />
					<actual value="4.80" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="4.02" />
					<actual value="3.10" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-12-31" />
					<target value="8.10" />
					<actual value="7.90" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
				</title>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="1232" />
					<actual value="389" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-09-30" />
					<target value="2449" />
					<actual value="900" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="1217" />
					<actual value="511" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="1557" />
					<actual value="435" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="1347" />
					<actual value="512" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2114" />
					<actual value="751" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-12-31" />
					<target value="3461" />
					<actual value="1263" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="14.62" />
					<actual value="27.40" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-12-31" />
					<target value="29.20" />
					<actual value="70.20" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="7.55" />
					<actual value="24.40" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-09-30" />
					<target value="18.90" />
					<actual value="38.20" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="11.93" />
					<actual value="5.30" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="11.32" />
					<actual value="13.80" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="14.60" />
					<actual value="42.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="31.44" />
					<actual value="27.70" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-09-30" />
					<target value="52.40" />
					<actual value="46.40" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="39.80" />
					<actual value="25.20" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="34.79" />
					<actual value="36.90" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="20.96" />
					<actual value="18.70" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-12-31" />
					<target value="69.60" />
					<actual value="67.10" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="34.78" />
					<actual value="30.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-12-31" />
					<target value="46.60" />
					<actual value="46.10" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="28.70" />
					<actual value="30.00" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="16.49" />
					<actual value="13.10" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="21.01" />
					<actual value="5.00" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-09-30" />
					<target value="33.00" />
					<actual value="21.90" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="17.93" />
					<actual value="16.10" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="16.49" />
					<actual value="8.70" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="7.32" />
					<actual value="9.60" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-09-30" />
					<target value="18.30" />
					<actual value="17.70" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="11.10" />
					<actual value="13.60" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="10.98" />
					<actual value="8.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="14.64" />
					<actual value="13.40" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="11.09" />
					<actual value="19.40" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-12-31" />
					<target value="22.20" />
					<actual value="33.00" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for THA-C-RTFP03</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="90.00" />
					<actual value="70.00" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="65.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="124" />
					<actual value="102" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="119" />
					<actual value="100.38" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="75.00" />
					<actual value="70.00" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="75.00" />
					<actual value="72.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="90.00" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV who report experiences of HIV-related discrimination in health-care settings</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="10.00" />
					<actual value="8.65" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reporting condom use at last sex</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="50.00" />
					<actual value="32.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV and on ART who are virologically suppressed</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="99.00" />
					<actual value="85.83" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="99.00" />
					<actual value="87.25" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reporting using sterile injecting equipment the last time they injected</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="95.00" />
					<actual value="86.70" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV who know their HIV status at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="100.00" />
					<actual value="102.30" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="91.24" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people diagnosed with TB who report stigma in health care settings that inhibited them from seeking and accessing TB services</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="10.00" />
					<actual value="9.07" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of transgender people reporting using a condom in their last anal sex with a non-regular male partner</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="79.53" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reporting using a condom with their most recent client</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="95.00" />
					<actual value="94.71" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of other vulnerable populations who report the use of a condom at last sexual intercourse</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="50.00" />
					<actual value="30.67" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men reporting using a condom the last time they had anal sex with a male partner</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.00" />
					<actual value="86.40" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for THA-C-RTFP03</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of new HIV infections per 1000 uninfected population</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="5000" />
					<actual value="0.84" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="0.06" />
					<actual value="0.09" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="0.06" />
					<actual value="0.13" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of AIDS-related deaths per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="8679" />
					<actual value="16.07" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="11.9" />
					<actual value="13.36" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="10.4" />
					<actual value="15.38" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="11" />
					<actual value="16" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="12" />
					<actual value="13" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of transgender people who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-09-30" />
					<target value="144" />
					<actual value="4.15" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="9.00" />
					<actual value="2.18" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB incidence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="138" />
					<actual value="143" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="133" />
					<actual value="155" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="7.20" />
					<actual value="8.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of other vulnerable populations (specify) who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1.00" />
					<actual value="0.25" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="10.00" />
					<actual value="1.69" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-12-31" />
					<target value="3.00" />
					<actual value="4.25" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-THA-C-RTF-4</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Stop TB and AIDS through RRTTPR 2024-2026 (STAR 2024-26) - Thailand (01-Jan-2024-31-Dec-2026)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Thailand, TB/HIV, Raks Thai Foundation (Raks Thai)This program has the following goals: To end AIDS by reducing 6,600 new infections and 12,115 AIDS-related deaths in 2020 to 2,700 cases and 6,600, by 2026.  To further advance to end TB and approach the pre-Elimination phase by reducing TB incidence from 143 per 100,000 in 2021 to 129 per 100,000 in 2026.  To develop a fully integrated nationwide system of health services, encompassing HIV, HCV and TB,  better suited to the needs of key populations and vulnerable people and enabling Thailand to reach its intended goals of eliminating those three diseases by 2030.. The objectives of this program are: To develop people-centered, community-based integrated services offering HIV, TB, STI, HCV, SRH, mental health, and social support to those most at risk or most vulnerable: MSM, MSW, TG, FSW, PWID, PWUD, migrants, prisoners, youth and elderly, urban poor who are at risk of TB.  To strengthen communities for community-led monitoring, conduct community-led research and data use for advocacy and establish CBOs learning network and to institutionalize the capacity building and certification process of CBOs, foster community / government / private partnerships and enlist private facilities for both HIV and TB services.  To identify key barriers and facilitating factors to access health services by conducting formative research / assessments to inform intervention for human rights, genders and S&amp;D.  To prevent new HIV infections and reduce number of PLHIV deaths by rapidly scaling up PrEP services, removing PrEP service provision barriers due to law and regulations, placing 116,000 PLHIV who have detectable viral load on effective ART, and ensuring early diagnosis by national expansion of HIV self-test, linkage to confirmatory test and same-day ART, promoting treatment adherence to reach durable viral load suppression..  To expand molecular diagnostic techniques for TB and access to curable TB treatment as well as to intensify screening of close contacts of index cases and other risk groups and KVPs, while ensuring universal access to quality diagnosis and treatment as to approach the 90-90-90 TB targets (reach 90% of people with TB, and KVP, and achieve 90% treatment success) and zero transmission.  To screen for TBI, within the WHO-recommended target groups, 80% of the eligible individuals, testing 80% of them and achieving treatment completion of 80% of those starting TPT.  To focus intensive efforts on people who inject drugs for harm reduction including HIV prevention, HIV treatment, HCV cure, treatment for addiction-related issues and social and legal support and to address the growing number of young people who use drugs, especially for chemsex use among MSM.  To focus special attention on migrants to decrease the burden of TB, bilateral collaboration for cross-border referral system and other related issues, as well as improvement of health insurance systems to ensure access to health services including TB/HUV/HCV/STIs..  To focus special attention on prisoners to decrease the burden of TB, the risk of HIV acquisition in prison settings and the continuity of ART on release from prison.  To mobilize and increase domestic funding at all level to support for community efforts to end HIV, TB and related diseases.</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="15" role="2">
			<narrative xml:lang="en">Raks Thai Foundation</narrative>
		</participating-org>
		<participating-org type="15" role="3">
			<narrative xml:lang="en">Raks Thai Foundation</narrative>
		</participating-org>
		<participating-org type="15" role="4">
			<narrative xml:lang="en">Raks Thai Foundation</narrative>
		</participating-org>
		<other-identifier ref="THA-C-RTFP04" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="2" />
		<activity-date type="1" iso-date="2024-01-01" />
		<activity-date type="2" iso-date="2024-01-01" />
		<activity-date type="3" iso-date="2026-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Philippe, CREACH</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>philippe.creach@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="TH" percentage="100">
			<narrative xml:lang="en">Thailand</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="63">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="25">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="2">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="10">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="16">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Community empowerment for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programing for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Community empowerment for OVP</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; HIV prevention communication, information and demand creation for OVP</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for OVP</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; Condom and lubricant programing for prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Community empowerment for PUD</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Condom and lubricant programing for PUD</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="22">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; HIV prevention communication, information and demand creation for PUD</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="6">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Needle and syringe programs for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Opioid substitution therapy and other medically assisted drug dependence treatment for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Overdose prevention and management for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programing for PUD</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Removing human rights-related barriers to prevention for PUD</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for PUD</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programing for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Community empowerment for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Condom and lubricant programing for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; HIV prevention communication, information and demand creation for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for transgender people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and polices relating to HIV and HIV/TB</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Diagnosis and management of advanced disease (adults and children)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Integrated management of common co-infections and co-morbidities (adults and children)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="25">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Community health workers: In-service training</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Mobile population (migrants/refugees/IDPs)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="6">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Key populations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2025-01-01" />
			<period-end iso-date="2025-12-31" />
			<value currency="USD" value-date="2024-01-01">13881235.05</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2024-01-01">13962109.88</value>
		</budget>
		<transaction ref="07038995-7ae0-430b-9892-8de0f66dfbb4">
			<transaction-type code="2" />
			<transaction-date iso-date="2026-01-29" />
			<value currency="USD" value-date="2026-01-29">-91666.90</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7f424e4e-b494-423d-9e2a-cc50557451cd">
			<transaction-type code="2" />
			<transaction-date iso-date="2026-01-22" />
			<value currency="USD" value-date="2026-01-22">10069470.93</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1d9cb3e7-7124-4004-8525-34788318197a">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-05-16" />
			<value currency="USD" value-date="2025-05-16">3071310.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8a0bb85f-44ac-477c-b088-7c4bc3681df3">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-05-16" />
			<value currency="USD" value-date="2025-05-16">-8451.15</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a22529c3-9462-466d-9f8a-9d4d2afa9429">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-04-03" />
			<value currency="USD" value-date="2025-04-03">91666.90</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="62568712-17eb-40f6-a85b-876a355f1eb3">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-12-20" />
			<value currency="USD" value-date="2023-12-20">14518422.17</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="15a16d03-156a-4c8c-82ef-aa2b74fe1be9">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-05-07" />
			<value currency="USD" value-date="2024-05-07">2183198.09</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8e9ac75e-e6b2-49d2-913b-dfedb5fb3938">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-11-04" />
			<value currency="USD" value-date="2025-11-04">1223984.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1dc0ae4d-56ae-4309-b339-960c5058c69c">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-02-04" />
			<value currency="USD" value-date="2025-02-04">5660549.19</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="95333800-2e3e-4055-b4da-da124e0e17ad">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-05-20" />
			<value currency="USD" value-date="2025-05-20">1847326.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b3c3e5ec-e7b9-45e5-acf0-9def8cdb45fd">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-12-22" />
			<value currency="USD" value-date="2023-12-22">1785159.22</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="70f60482-8eca-40a7-8d3d-1a8b83920b1f">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-11-01" />
			<value currency="USD" value-date="2024-11-01">2647850.46</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="50a947be-cb85-4578-ada8-1d88448411a7">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-07-30" />
			<value currency="USD" value-date="2024-07-30">2233214.06</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6f6eabf5-029f-418d-9970-674035afbad3">
			<transaction-type code="3" />
			<transaction-date iso-date="2026-01-27" />
			<value currency="USD" value-date="2026-01-27">3666120.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP04.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/THA-C-RTF" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-THA-C-RTF-1</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Investing for Impact against Tuberculosis and HIV - Thailand (01-Jan-2015-31-Dec-2017)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Thailand, TB/HIV, Raks Thai Foundation (Raks Thai)This program has the following goals: To end AIDS in Thailand by 2030 (reducing annual new infections to below 1000 cases (from the current 8,134 estimated new infections annually).  To reduce the prevalence of TB from 159 per 100,000 to 120 per 100,000 between 2015-2019. The objectives of this program are: Objective 1: To prevent the transmission of HIV and TB by sustaining intensive behavior change activities, appropriate use of prophylaxis and the strategic use of anti-retroviral drugs.  Objective 2: Actively find HIV and TB cases in the community and health care settings by recruiting   'at risk' and 'vulnerable populations' into HIV testing and TB screening..  Objective 3: To ensure early and accurate diagnosis of both diseases by improving diagnostic capability, and reducing turn-around time (by using rapid HIV testing and molecular diagnostic techniques for TB).  Objective 4: To provide early treatment and ensure retention in care for all those diagnosed with HIV and/or TB..  Objective 5: To foster collaborative activities across HIV and TB programs at national and sub-national levels, and ensure sustainability by strengthening linkages between community and health systems..  Objective 6: To normalize HIV/TB and reduce stigma and discrimination.</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="15" role="2">
			<narrative xml:lang="en">Raks Thai Foundation</narrative>
		</participating-org>
		<participating-org type="15" role="3">
			<narrative xml:lang="en">Raks Thai Foundation</narrative>
		</participating-org>
		<participating-org type="15" role="4">
			<narrative xml:lang="en">Raks Thai Foundation</narrative>
		</participating-org>
		<other-identifier ref="THA-C-RTFP01" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2015-01-01" />
		<activity-date type="2" iso-date="2015-01-01" />
		<activity-date type="3" iso-date="2017-12-31" />
		<activity-date type="4" iso-date="2017-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Philippe, CREACH</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>philippe.creach@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="TH" percentage="100">
			<narrative xml:lang="en">Thailand</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="100">
			<narrative xml:lang="en">TB/HIV</narrative>
		</sector>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<transaction ref="28ca7741-f194-40db-8fb5-df93b6854d4b">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-01-15" />
			<value currency="USD" value-date="2019-01-15">-51075.91</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="de8cf2ec-b529-42a0-8dcb-d4988ee561ca">
			<transaction-type code="2" />
			<transaction-date iso-date="2015-01-22" />
			<value currency="USD" value-date="2015-01-22">14247023.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e6019dcc-8465-48a3-ba88-1e9641cbbd44">
			<transaction-type code="2" />
			<transaction-date iso-date="2016-04-19" />
			<value currency="USD" value-date="2016-04-19">8695275.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a3d737dc-7f3f-40a9-b169-36c7336f5337">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-02-20" />
			<value currency="USD" value-date="2017-02-20">-7226032.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f67c84c1-4bff-4592-bb61-b9d5a930101e">
			<transaction-type code="2" />
			<transaction-date iso-date="2015-01-16" />
			<value currency="USD" value-date="2015-01-16">13892919.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="70854d3b-25db-4f13-a8b9-724c5d80b1d1">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-02-20" />
			<value currency="USD" value-date="2017-02-20">10107118.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2b396ae3-7112-4b57-bfd3-5627f8561138">
			<transaction-type code="2" />
			<transaction-date iso-date="2015-01-27" />
			<value currency="USD" value-date="2015-01-27">-13892919.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5d85b417-9c76-4cca-8e16-b90c8602b59f">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-12-18" />
			<value currency="USD" value-date="2018-12-18">-244763.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="de51e557-14d7-400e-a09e-42638ebdc92a">
			<transaction-type code="2" />
			<transaction-date iso-date="2016-04-19" />
			<value currency="USD" value-date="2016-04-19">-4133315.65</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5e1a7374-4011-4698-b7cc-3d1b2bd4ec46">
			<transaction-type code="3" />
			<transaction-date iso-date="2015-09-22" />
			<value currency="USD" value-date="2015-09-22">1992683.35</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5bbd9fe1-9abd-4b04-acfe-6d79774d6f8f">
			<transaction-type code="7" />
			<transaction-date iso-date="2019-01-11" />
			<value currency="USD" value-date="2019-01-11">-51075.91</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP01.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a9d638d5-64b9-4a34-bd49-f074a420a30a">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-07-27" />
			<value currency="USD" value-date="2017-07-27">2087468.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f897cece-779b-420a-b3c7-817ad2a4d0c5">
			<transaction-type code="3" />
			<transaction-date iso-date="2015-06-23" />
			<value currency="USD" value-date="2015-06-23">2383468.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a233a3c9-8d64-40d4-98f5-e5c16f93a02d">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-11-24" />
			<value currency="USD" value-date="2017-11-24">2853798.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="dec53492-5d29-436b-926f-078023941c26">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-02-21" />
			<value currency="USD" value-date="2017-02-21">2883127.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fa66f941-3fe2-4797-9425-5506b4d75537">
			<transaction-type code="3" />
			<transaction-date iso-date="2015-01-28" />
			<value currency="USD" value-date="2015-01-28">3085834.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f3ff76ae-3d35-4438-ada0-ed3f30879062">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-01-04" />
			<value currency="USD" value-date="2016-01-04">710928.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="406802de-b176-4050-b66e-636c65d2abdc">
			<transaction-type code="3" />
			<transaction-date iso-date="2015-03-17" />
			<value currency="USD" value-date="2015-03-17">1940794.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2321894b-02bb-44d0-8aeb-d92da20417d6">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-05-16" />
			<value currency="USD" value-date="2017-05-16">2037962.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="83840c2f-9b99-4f20-b730-26e93a52fdbe">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-04-21" />
			<value currency="USD" value-date="2016-04-21">1469243.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/THA-C-RTF" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for THA-C-RTFP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2016-10-01" />
					<period-end iso-date="2017-03-31" />
					<target value="14.60" />
					<actual value="19.60" />
				</period>
				<period>
					<period-start iso-date="2017-04-01" />
					<period-end iso-date="2017-09-30" />
					<target value="26.60" />
					<actual value="32.00" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="6.70" />
					<actual value="8.30" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-09-30" />
					<target value="17.70" />
					<actual value="11.40" />
				</period>
				<period>
					<period-start iso-date="2016-04-01" />
					<period-end iso-date="2016-09-30" />
					<target value="25.90" />
					<actual value="43.30" />
				</period>
				<period>
					<period-start iso-date="2015-10-01" />
					<period-end iso-date="2016-03-31" />
					<target value="13.90" />
					<actual value="24.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">KP- other 1: Percentage of male sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2017-04-01" />
					<period-end iso-date="2017-09-30" />
					<target value="83.10" />
					<actual value="96.10" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="20.80" />
					<actual value="30.90" />
				</period>
				<period>
					<period-start iso-date="2015-10-01" />
					<period-end iso-date="2016-03-31" />
					<target value="43.40" />
					<actual value="56.00" />
				</period>
				<period>
					<period-start iso-date="2016-10-01" />
					<period-end iso-date="2017-03-31" />
					<target value="45.70" />
					<actual value="49.30" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-09-30" />
					<target value="55.40" />
					<actual value="35.40" />
				</period>
				<period>
					<period-start iso-date="2016-04-01" />
					<period-end iso-date="2016-09-30" />
					<target value="80.80" />
					<actual value="106.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2017-04-01" />
					<period-end iso-date="2017-09-30" />
					<target value="53.10" />
					<actual value="41.80" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="1.50" />
					<actual value="4.90" />
				</period>
				<period>
					<period-start iso-date="2016-10-01" />
					<period-end iso-date="2017-03-31" />
					<target value="21.00" />
					<actual value="22.00" />
				</period>
				<period>
					<period-start iso-date="2015-10-01" />
					<period-end iso-date="2016-03-31" />
					<target value="26.10" />
					<actual value="21.20" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-09-30" />
					<target value="29.50" />
					<actual value="13.60" />
				</period>
				<period>
					<period-start iso-date="2016-04-01" />
					<period-end iso-date="2016-09-30" />
					<target value="53.00" />
					<actual value="42.90" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2016-04-01" />
					<period-end iso-date="2016-09-30" />
					<target value="33.00" />
					<actual value="20.00" />
				</period>
				<period>
					<period-start iso-date="2016-10-01" />
					<period-end iso-date="2017-03-31" />
					<target value="16.90" />
					<actual value="14.70" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-09-30" />
					<target value="23.70" />
					<actual value="10.20" />
				</period>
				<period>
					<period-start iso-date="2017-04-01" />
					<period-end iso-date="2017-09-30" />
					<target value="33.90" />
					<actual value="21.30" />
				</period>
				<period>
					<period-start iso-date="2015-10-01" />
					<period-end iso-date="2016-03-31" />
					<target value="16.10" />
					<actual value="12.50" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="6.80" />
					<actual value="8.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2016-10-01" />
					<period-end iso-date="2017-03-31" />
					<target value="22.10" />
					<actual value="6.00" />
				</period>
				<period>
					<period-start iso-date="2017-04-01" />
					<period-end iso-date="2017-09-30" />
					<target value="47.90" />
					<actual value="57.40" />
				</period>
				<period>
					<period-start iso-date="2016-04-01" />
					<period-end iso-date="2016-09-30" />
					<target value="36.10" />
					<actual value="56.40" />
				</period>
				<period>
					<period-start iso-date="2015-10-01" />
					<period-end iso-date="2016-03-31" />
					<target value="17.70" />
					<actual value="27.00" />
				</period>
				<period>
					<period-start iso-date="2015-01-01" />
					<period-end iso-date="2015-09-30" />
					<target value="24.10" />
					<actual value="31.40" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="14.70" />
					<actual value="14.90" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of needles and syringes distributed per person who injects drugs per year by needle and syringe programs</narrative>
				</title>
				<period>
					<period-start iso-date="2017-04-01" />
					<period-end iso-date="2017-09-30" />
					<target value="88" />
					<actual value="61" />
				</period>
				<period>
					<period-start iso-date="2016-04-01" />
					<period-end iso-date="2016-09-30" />
					<target value="88" />
					<actual value="71" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for THA-C-RTFP01</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Modelled lives saved based on latest epidemiological data</narrative>
				</title>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="2939" />
					<actual value="300" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="1034" />
					<actual value="300" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="2366" />
					<actual value="300" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="1034" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="2366" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="2939" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB prevalence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="150" />
					<actual value="236" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="140" />
					<actual value="236" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="230" />
					<actual value="236" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="12" />
					<actual value="17.6" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="14" />
					<actual value="17.6" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="11" />
					<actual value="17.6" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="12" />
					<actual value="18.7" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="14" />
					<actual value="18.7" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="11" />
					<actual value="18.7" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="2.90" />
					<actual value="1.00" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="3.50" />
					<actual value="1.00" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for THA-C-RTFP01</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="100" />
					<actual value="91.4" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="94" />
					<actual value="91.4" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="95" />
					<actual value="91.4" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="94" />
					<actual value="98.6" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="95" />
					<actual value="98.6" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="100" />
					<actual value="98.6" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adults and children with HIV, known to be on treatment 12 months after initiation of antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2017-04-01" />
					<period-end iso-date="2017-09-30" />
					<target value="90.00" />
					<actual value="86.90" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="95.00" />
					<actual value="89.49" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="100.00" />
					<actual value="89.49" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="87.00" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="83.00" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2017-12-31" />
					<target value="85.00" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-THA-C-RTF-2</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Stop TB and AIDS through RTTR (STAR) - Thailand (01-Jan-2018-31-Dec-2020)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Thailand, TB/HIV, Raks Thai Foundation (Raks Thai)This program has the following goals: To end AIDS by reducing 6,176 HIV new infections in 2016 to below 1,000 by 2030.  To reduce the TB incidence from 172 in 2016 to 88 per 100,000 by 2021. The objectives of this program are: To prevent the transmission of HIV and TB by susting intensive behavior change activities, appropriate use of prophylaxis and strategic use of ant-retroviral drugs.  Actively find HIV and TB cases in the community and health care settings by recruiting 'at risk' and vulnerable populations into HIV testing and TB screening.  To ensure early and accurate diagnosis of both diseases by improving diagnostic capability, and reducing turn-around time (by using rapid HIV testing and molecular diagnostic techniques for TB).  To provide early treatment and ensure retention in care for all those diagnosed with HIV and/or TB.  To foster collaborative activities across HIV and TB programs at national and sub-national levels and ensure sustainability by strengthening linkages between community and health systems.  To prepare Thailand to transition fully to sustained domestic funding and efficient implementaion system through a partnership between communities, private and public sectors</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="15" role="2">
			<narrative xml:lang="en">Raks Thai Foundation</narrative>
		</participating-org>
		<participating-org type="15" role="3">
			<narrative xml:lang="en">Raks Thai Foundation</narrative>
		</participating-org>
		<participating-org type="15" role="4">
			<narrative xml:lang="en">Raks Thai Foundation</narrative>
		</participating-org>
		<other-identifier ref="THA-C-RTFP02" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2018-01-01" />
		<activity-date type="2" iso-date="2018-01-01" />
		<activity-date type="3" iso-date="2020-12-31" />
		<activity-date type="4" iso-date="2020-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Philippe, CREACH</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>philippe.creach@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="TH" percentage="100">
			<narrative xml:lang="en">Thailand</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="56">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="22">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="10">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="12">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for MSM -&gt; Behavioral interventions for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for MSM -&gt; HIV testing services for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; Behavioral interventions for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; Community empowerment for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; HIV testing services for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; Interventions for young people who inject drugs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; Needle and Syringe programs for PWID and their partners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; OST and other drug dependence treatment for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="23">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; Prevention and management of coinfections and co-morbidities for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for TGs -&gt; Behavioral interventions for TGs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for TGs -&gt; HIV testing services for TGs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive programs for people in prisons and other closed settings -&gt; Condoms and lubricant programming for people in prisons and other closed settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Community empowerment for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="11">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for other vulnerable populations -&gt; Behavioral interventions for other vulnerable populations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for other vulnerable populations -&gt; Diagnosis and treatment of STIs and other sexual health services for other vulnerable populations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for other vulnerable populations -&gt; HIV testing services for other vulnerable populations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for other vulnerable populations -&gt; Male and female condoms for other vulnerable populations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and polices relating to HIV and HIV/TB</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy (“Know Your Rights” campaign)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Sensitization of law-makers and law-enforcement agents</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment adherence</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="22">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health sector governance and planning -&gt; National health sector strategies and financing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="7">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Community TB/HIV care delivery</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2019-01-01" />
			<period-end iso-date="2019-12-31" />
			<value currency="USD" value-date="2018-01-01">7128180.86</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2020-01-01" />
			<period-end iso-date="2020-12-31" />
			<value currency="USD" value-date="2018-01-01">6370185.08</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2018-01-01" />
			<period-end iso-date="2018-12-31" />
			<value currency="USD" value-date="2018-01-01">6133801.35</value>
		</budget>
		<transaction ref="266ee642-9015-4812-a241-af360be0b944">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-02-13" />
			<value currency="USD" value-date="2020-02-13">8363198.26</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b14c245b-b41a-496d-b5ed-5221a77ec4bf">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-03-06" />
			<value currency="USD" value-date="2019-03-06">-1920318.09</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b37a2030-cdab-4ea6-843a-fd569df63fc5">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-03-06" />
			<value currency="USD" value-date="2019-03-06">6553815.78</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="341eee36-dc94-4abb-9c2b-70c59333b015">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-01-25" />
			<value currency="USD" value-date="2018-01-25">6133801.35</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3fff4d0f-ae68-4a01-9727-e84c6d9dc239">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-02-13" />
			<value currency="USD" value-date="2020-02-13">-643994.50</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c4f552ba-70d0-40ef-84b8-74c40745b538">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-10-18" />
			<value currency="USD" value-date="2019-10-18">1753799.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3bee64d2-2de0-4ac4-963e-2d00be7d33a5">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-08-05" />
			<value currency="USD" value-date="2020-08-05">1161856.01</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8170aca5-cbcc-45a4-9997-16f760f88061">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-02-13" />
			<value currency="USD" value-date="2018-02-13">1418831.26</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1bba9560-99ef-4992-8aac-e595e0e3ebe3">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-06-02" />
			<value currency="USD" value-date="2020-06-02">1063693.68</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="13b0db65-6684-45dc-b010-00bb3dc672b2">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-08-24" />
			<value currency="USD" value-date="2018-08-24">1442127.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0c96b40a-5ca3-4f34-9432-c702a7df8c3b">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-02-14" />
			<value currency="USD" value-date="2020-02-14">3653820.22</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1f4e186d-7d76-4384-af24-fbc9607a6f1f">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-11-22" />
			<value currency="USD" value-date="2018-11-22">1352525.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e816027a-3949-46d1-b3aa-23c817407f36">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-06-04" />
			<value currency="USD" value-date="2019-06-04">933832.50</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="77c51ec1-8255-47ef-ae99-b0b2aff93a97">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-03-08" />
			<value currency="USD" value-date="2019-03-08">1787176.78</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="774434a6-9cf9-4618-9270-bb4b7a23e8ae">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-11-19" />
			<value currency="USD" value-date="2020-11-19">2483828.35</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a0a5cb98-41f6-41c5-82ce-636d6025bdb6">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-08-13" />
			<value currency="USD" value-date="2019-08-13">1435013.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to THA-C-RTFP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">Raks Thai Foundation (Raks Thai)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/THA-C-RTF" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for THA-C-RTFP02</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2018-10-01" />
					<period-end iso-date="2019-03-31" />
					<target value="41.00" />
					<actual value="56.00" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="72.00" />
					<actual value="79.90" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-09-30" />
					<target value="56.00" />
					<actual value="40.90" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="42.50" />
					<actual value="54.70" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="43.50" />
					<actual value="56.90" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="35.00" />
					<actual value="26.60" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="25.00" />
					<actual value="24.80" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="0" />
					<actual value="17.30" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-09-30" />
					<target value="42.00" />
					<actual value="22.60" />
				</period>
				<period>
					<period-start iso-date="2018-10-01" />
					<period-end iso-date="2019-03-31" />
					<target value="28.00" />
					<actual value="24.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="38.40" />
					<actual value="20.70" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="21.00" />
					<actual value="19.80" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-09-30" />
					<target value="25.20" />
					<actual value="18.00" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="22.20" />
					<actual value="20.50" />
				</period>
				<period>
					<period-start iso-date="2018-10-01" />
					<period-end iso-date="2019-03-31" />
					<target value="19.20" />
					<actual value="17.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="28.60" />
					<actual value="19.50" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="32.80" />
					<actual value="11.70" />
				</period>
				<period>
					<period-start iso-date="2018-10-01" />
					<period-end iso-date="2019-03-31" />
					<target value="32.80" />
					<actual value="16.30" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-09-30" />
					<target value="52.50" />
					<actual value="15.20" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="36.10" />
					<actual value="19.10" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of needles and syringes distributed per person who injects drugs per year by needle and syringe programs</narrative>
				</title>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="115" />
					<actual value="67.67" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="115" />
					<actual value="16.94" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-09-30" />
					<target value="115" />
					<actual value="66.52" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-09-30" />
					<target value="25.20" />
					<actual value="2.40" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="15.00" />
					<actual value="3.90" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="19.50" />
					<actual value="4.10" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="16.70" />
					<actual value="4.40" />
				</period>
				<period>
					<period-start iso-date="2018-10-01" />
					<period-end iso-date="2019-03-31" />
					<target value="16.30" />
					<actual value="2.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2018-10-01" />
					<period-end iso-date="2019-03-31" />
					<target value="28.10" />
					<actual value="19.50" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="0" />
					<actual value="15.50" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="25.00" />
					<actual value="15.70" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="35.00" />
					<actual value="18.80" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-09-30" />
					<target value="42.00" />
					<actual value="19.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="0" />
					<actual value="9.40" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="18.00" />
					<actual value="12.20" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-09-30" />
					<target value="19.40" />
					<actual value="6.10" />
				</period>
				<period>
					<period-start iso-date="2018-10-01" />
					<period-end iso-date="2019-03-31" />
					<target value="13.10" />
					<actual value="7.30" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="12.00" />
					<actual value="13.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of transgender people that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2018-10-01" />
					<period-end iso-date="2019-03-31" />
					<target value="13.40" />
					<actual value="7.80" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="12.00" />
					<actual value="5.90" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="17.90" />
					<actual value="7.60" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="0" />
					<actual value="8.20" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-09-30" />
					<target value="20.20" />
					<actual value="3.40" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
				</title>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="722" />
					<actual value="96" />
				</period>
				<period>
					<period-start iso-date="2018-10-01" />
					<period-end iso-date="2019-03-31" />
					<target value="683" />
					<actual value="124" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-09-30" />
					<target value="918" />
					<actual value="224" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="1258" />
					<actual value="142" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="747" />
					<actual value="186" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for THA-C-RTFP02</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="7" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="6" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="6" />
					<actual value="14" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="7" />
					<actual value="14" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB incidence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="100" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="115" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="100" />
					<actual value="150" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="115" />
					<actual value="150" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of AIDS-related deaths per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="16.16" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="18.11" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="16.16" />
					<actual value="17.07" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="18.11" />
					<actual value="17.07" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of new HIV infections per 1000 uninfected population</narrative>
				</title>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="0.04" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="0.06" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="0.06" />
					<actual value="0.07" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="0.04" />
					<actual value="0.07" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for THA-C-RTFP02</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="70.01" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="75.02" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="75.02" />
					<actual value="54.05" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="70.01" />
					<actual value="54.05" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="87.00" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.00" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="87.00" />
					<actual value="72275" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.00" />
					<actual value="72275" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="85.00" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.00" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.00" />
					<actual value="83.61" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="85.00" />
					<actual value="83.61" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="146" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="150" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="150" />
					<actual value="125" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="146" />
					<actual value="125" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adults and children with HIV, known to be on treatment 12 months after initiation of antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="93.00" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="92.00" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="92.00" />
					<actual value="89.22" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="93.00" />
					<actual value="89.22" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of (estimated) people living with HIV who have been tested HIV-positive</narrative>
				</title>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="94.00" />
					<actual value="105.22" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="93.00" />
					<actual value="103.39" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reporting using sterile injecting equipment the last time they injected</narrative>
				</title>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-12-31" />
					<target value="98.00" />
					<actual value="64.41" />
				</period>
			</indicator>
		</result>
	</iati-activity>
</iati-activities>